Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

US-friendly broker Finpari

 

Enter Stock Symbol:  

Celldex Therapeutics (CLDX)

3.33 +0.06 (+1.83%)

3/24/2017  4:00pm

Open:

3.29

Pre. Close:

3.27

High:

3.33

Low:

3.22

Volume:

1,281,042

Market Cap:

410.30M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

3.37 - 3.41

3.41 - 3.48

Low:

3.07 - 3.11

3.11 - 3.18

Close:

3.24 - 3.31

3.31 - 3.44

Technical analysis  (as of: 2017-03-24 4:32:55 PM)

Overall:

      

Stoxline posted a BUY today, upgraded from lower rating. This stock seems to be ready for a new bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, a new upward move is expected.

Target:

Six months: 4.20     One year: 4.60

Support:

Support1: 3.05    Support2: 2.54

Resistance:

Resistance1: 3.60    Resistance2: 3.94

Pivot:

3.41

Moving Averages:

MA(5): 3.28     MA(20): 3.45

MA(100): 3.63     MA(250): 3.92

MACD:

MACD(12,26): -0.05     Signal(12,26,9): -0.03

%K %D:

%K(14,3): 25.84     %D(3): 19.98

RSI:

RSI(14): 46.69

52-Week:

High: 5.13  Low: 2.85  Change(%): -10.2

Average Vol(K):

3-Month: 1914  10-Days 2199

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
CLDX has closed above bottom band by 37.0%. Bollinger Bands are 30.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Tue, 14 Mar 2017 22:23:15 GMT
Celldex Therapeutics, Inc. Ends Q4 With Plenty of Cash and Several Key Studies ...

Tue, 07 Mar 2017 21:43:16 GMT
Celldex Therapeutics, Inc. Is Feeling Some Pressure Today -- Here's Why

Tue, 28 Feb 2017 12:28:06 GMT
Better Buy: Celldex Therapeutics, Inc. vs. Juno Therapeutics Inc

Fri, 10 Mar 2017 19:42:17 GMT
Better Buy: Agenus Inc. vs. Celldex Therapeutics

Fri, 24 Mar 2017 16:41:15 GMT
Cantor Fitzgerald Analysts Increase Earnings Estimates for Celldex ...

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology Medical Research

Shares Out. (M)

122.28

Shares Float (M)

115.45

% Held by Insiders

0.54

% Held by Institutions

89.20

Shares Short (K)

19190

Shares Short Prior Month (K)

19190

Stock Financials

EPS

-1.270

EPS Est. Current Year

EPS Est. Next Year

EPS Est. Next Quarter

Forward EPS

Book Value (p.s.)

2.150

PEG Ratio

Profit Margin

Operating Margin

-1958.68

Return on Assets (ttm)

-23.0

Return on Equity (ttm)

-46.3

Qtrly Rev. Growth

4.6

Gross Profit (p.s.)

0.045

Sales Per Share

0.056

EBITDA (p.s.)

-1.053

Qtrly Earnings Growth

Operating Cash Flow (M)

-113.04

Levered Free Cash Flow (M)

-77.49

FoxReading.com

Valuation

P/E

-2.62

P/E Growth Ratio

0.02

P/BV

1.55

P/S

59.97

P/CF

-3.60

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

0.083

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.